262 related articles for article (PubMed ID: 33130223)
1. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology.
Pentz R; Iulita MF; Mikutra-Cencora M; Ducatenzeiler A; Bennett DA; Cuello AC
Neurobiol Dis; 2021 Jan; 148():105150. PubMed ID: 33130223
[TBL] [Abstract][Full Text] [Related]
2. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease.
Iulita MF; Bistué Millón MB; Pentz R; Aguilar LF; Do Carmo S; Allard S; Michalski B; Wilson EN; Ducatenzeiler A; Bruno MA; Fahnestock M; Cuello AC
Neurobiol Dis; 2017 Dec; 108():307-323. PubMed ID: 28865749
[TBL] [Abstract][Full Text] [Related]
3. The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease.
Pentz R; Iulita MF; Ducatenzeiler A; Bennett DA; Cuello AC
Mol Psychiatry; 2021 Oct; 26(10):6023-6037. PubMed ID: 32488129
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
Pentz R; Iulita MF; Ducatenzeiler A; Videla L; Benejam B; Carmona‐Iragui M; Blesa R; Lleó A; Fortea J; Cuello AC
Alzheimers Dement; 2021 Apr; 17(4):605-617. PubMed ID: 33226181
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
[TBL] [Abstract][Full Text] [Related]
6. The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic Atrophy.
Do Carmo S; Kannel B; Cuello AC
Cells; 2021 Dec; 11(1):. PubMed ID: 35011577
[TBL] [Abstract][Full Text] [Related]
7. NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease.
Cuello AC; Bruno MA; Bell KF
Curr Alzheimer Res; 2007 Sep; 4(4):351-8. PubMed ID: 17908036
[TBL] [Abstract][Full Text] [Related]
8. The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease.
Iulita MF; Cuello AC
Curr Alzheimer Res; 2016; 13(1):53-67. PubMed ID: 26391047
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor metabolic dysfunction in Down's syndrome brains.
Iulita MF; Do Carmo S; Ower AK; Fortress AM; Flores Aguilar L; Hanna M; Wisniewski T; Granholm AC; Buhusi M; Busciglio J; Cuello AC
Brain; 2014 Mar; 137(Pt 3):860-72. PubMed ID: 24519975
[TBL] [Abstract][Full Text] [Related]
10. Increased matrix metalloproteinase 9 activity in mild cognitive impairment.
Bruno MA; Mufson EJ; Wuu J; Cuello AC
J Neuropathol Exp Neurol; 2009 Dec; 68(12):1309-18. PubMed ID: 19915485
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome.
Iulita MF; Cuello AC
Trends Pharmacol Sci; 2014 Jul; 35(7):338-48. PubMed ID: 24962069
[TBL] [Abstract][Full Text] [Related]
12. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.
Canu N; Amadoro G; Triaca V; Latina V; Sposato V; Corsetti V; Severini C; Ciotti MT; Calissano P
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632177
[TBL] [Abstract][Full Text] [Related]
13. proNGF Involvement in the Adult Neurogenesis Dysfunction in Alzheimer's Disease.
Olabiyi BF; Fleitas C; Zammou B; Ferrer I; Rampon C; Egea J; Espinet C
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639085
[TBL] [Abstract][Full Text] [Related]
14. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
Triaca V; Ruberti F; Canu N
Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
[TBL] [Abstract][Full Text] [Related]
15. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.
Fahnestock M; Michalski B; Xu B; Coughlin MD
Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181
[TBL] [Abstract][Full Text] [Related]
16. A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome.
Iulita MF; Caraci F; Cuello AC
CNS Neurol Disord Drug Targets; 2016; 15(4):434-47. PubMed ID: 26996175
[TBL] [Abstract][Full Text] [Related]
17. Preplaque ('preclinical') Aβ-induced inflammation and nerve growth factor deregulation in transgenic models of Alzheimer's disease-like amyloid pathology.
Cuello AC; Ferretti MT; Iulita MF
Neurodegener Dis; 2012; 10(1-4):104-7. PubMed ID: 22261363
[TBL] [Abstract][Full Text] [Related]
18. Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.
Perez SE; He B; Nadeem M; Wuu J; Scheff SW; Abrahamson EE; Ikonomovic MD; Mufson EJ
Biol Psychiatry; 2015 Apr; 77(8):693-703. PubMed ID: 24529280
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation.
Cuello AC; Bruno MA; Allard S; Leon W; Iulita MF
J Mol Neurosci; 2010 Jan; 40(1-2):230-5. PubMed ID: 19680822
[TBL] [Abstract][Full Text] [Related]
20. Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype.
Allard S; Leon WC; Pakavathkumar P; Bruno MA; Ribeiro-da-Silva A; Cuello AC
J Neurosci; 2012 Feb; 32(6):2002-12. PubMed ID: 22323714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
